Tectonic Therapeutic (TECX) Shares Issued (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Shares Issued of $2.2 million for Q1 2026, up 6724.72% year-over-year from $31891.0 in Q1 2025, and up 11.53% quarter-over-quarter from $2.0 million in Q4 2025.
Tectonic Therapeutic (TECX) Shares Issued (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Shares Issued for 10 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 6724.72% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 6724.72% YoY), while the FY2025 annual figure was $2.0 million, up 2010.1% from the prior year.
- Shares Issued advanced to $2.2 million in Q1 2026 per TECX's latest filing, from $2.0 million in the prior quarter.
- Across five years, Shares Issued topped out at $9.5 million in Q1 2022 and bottomed at $31891.0 in Q1 2025.
- Historically, Shares Issued has averaged $4.2 million across 5 years, with a median of $3.7 million in 2023.
- Annual changes were most pronounced in 2025 — Shares Issued sank 99.34% — and 2026, when it surged 6724.72%.
- Tectonic Therapeutic's Shares Issued stood at $9.4 million in 2022, then slumped by 89.36% to $1.0 million in 2023, then plunged by 90.77% to $92480.0 in 2024, then surged by 2010.1% to $2.0 million in 2025, then grew by 11.53% to $2.2 million in 2026.
- Business Quant data shows TECX's Shares Issued at $2.2 million in Q1 2026, $2.0 million in Q4 2025, and $31891.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.26 Mn |
| Jun 30, 2026 | 2.26 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Mar 31, 2025 | 31,891.00 |
| Mar 31, 2025 | 31,891.00 |
| Dec 31, 2024 | 92,480.00 |
| Dec 31, 2024 | 92,480.00 |
| Sep 30, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Jun 30, 2023 | 4.18 Mn |
| Jun 30, 2023 | 4.18 Mn |